Ivermectin: an award-winning drug with expected antiviral activity against COVID-19

DOI record: { "DOI": "10.1016/j.jconrel.2020.10.009", "ISSN": [ "0168-3659" ], "URL": "http://dx.doi.org/10.1016/j.jconrel.2020.10.009", "alternative-id": [ "S0168365920305800" ], "assertion": [ { "label": "This article is maintained by", "name": "publisher", "value": "Elsevier" }, { "label": "Article Title", "name": "articletitle", "value": "Ivermectin: an award-winning drug with expected antiviral activity against COVID-19" }, { "label": "Journal Title", "name": "journaltitle", "value": "Journal of Controlled Release" }, { "label": "CrossRef DOI link to publisher maintained version", "name": "articlelink", "value": "https://doi.org/10.1016/j.jconrel.2020.10.009" }, { "label": "Content Type", "name": "content_type", "value": "article" }, { "label": "Copyright", "name": "copyright", "value": "© 2020 Elsevier B.V. All rights reserved." } ], "author": [ { "ORCID": "http://orcid.org/0000-0003-1553-0533", "affiliation": [], "authenticated-orcid": false, "family": "Formiga", "given": "Fabio Rocha", "sequence": "first" }, { "affiliation": [], "family": "Leblanc", "given": "Roger", "sequence": "additional" }, { "affiliation": [], "family": "de Souza Rebouças", "given": "Juliana", "sequence": "additional" }, { "affiliation": [], "family": "Farias", "given": "Leonardo Paiva", "sequence": "additional" }, { "affiliation": [], "family": "de Oliveira", "given": "Ronaldo Nascimento", "sequence": "additional" }, { "affiliation": [], "family": "Pena", "given": "Lindomar", "sequence": "additional" } ], "container-title": "Journal of Controlled Release", "container-title-short": "Journal of Controlled Release", "content-domain": { "crossmark-restriction": true, "domain": [ "elsevier.com", "sciencedirect.com" ] }, "created": { "date-parts": [ [ 2020, 10, 7 ] ], "date-time": "2020-10-07T15:10:29Z", "timestamp": 1602083429000 }, "deposited": { "date-parts": [ [ 2022, 6, 26 ] ], "date-time": "2022-06-26T11:46:04Z", "timestamp": 1656243964000 }, "funder": [ { "DOI": "10.13039/501100003593", "doi-asserted-by": "publisher", "name": "Conselho Nacional de Desenvolvimento Científico e Tecnológico" }, { "DOI": "10.13039/501100000193", "doi-asserted-by": "publisher", "name": "International Development Research Centre" }, { "DOI": "10.13039/501100002322", "doi-asserted-by": "publisher", "name": "Coordenação de Aperfeiçoamento de Pessoal de Nível Superior" }, { "DOI": "10.13039/501100006162", "doi-asserted-by": "publisher", "name": "Fundação de Amparo à Ciência e Tecnologia do Estado de Pernambuco" }, { "DOI": "10.13039/501100006507", "doi-asserted-by": "publisher", "name": "Fundação Oswaldo Cruz" } ], "indexed": { "date-parts": [ [ 2024, 5, 14 ] ], "date-time": "2024-05-14T02:35:27Z", "timestamp": 1715654127631 }, "is-referenced-by-count": 50, "issued": { "date-parts": [ [ 2021, 1 ] ] }, "language": "en", "license": [ { "URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2021, 1, 1 ] ], "date-time": "2021-01-01T00:00:00Z", "timestamp": 1609459200000 } } ], "link": [ { "URL": "https://api.elsevier.com/content/article/PII:S0168365920305800?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://api.elsevier.com/content/article/PII:S0168365920305800?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining" } ], "member": "78", "original-title": [], "page": "758-761", "prefix": "10.1016", "published": { "date-parts": [ [ 2021, 1 ] ] }, "published-print": { "date-parts": [ [ 2021, 1 ] ] }, "publisher": "Elsevier BV", "reference": [ { "DOI": "10.1038/nature.2015.18507", "article-title": "Anti-parasite drugs sweep Nobel prize in medicine 2015", "author": "Callaway", "doi-asserted-by": "crossref", "first-page": "174", "journal-title": "Nature.", "key": "10.1016/j.jconrel.2020.10.009_bb0005", "volume": "526", "year": "2015" }, { "DOI": "10.1016/j.antiviral.2018.09.010", "article-title": "Ivermectin inhibits DNA polymerase UL42 of pseudorabies virus entrance into the nucleus and proliferation of the virus in vitro and vivo", "author": "Lv", "doi-asserted-by": "crossref", "first-page": "55", "journal-title": "Antivir. Res.", "key": "10.1016/j.jconrel.2020.10.009_bb0010", "volume": "159", "year": "2018" }, { "DOI": "10.1016/j.virusres.2019.01.010", "article-title": "Ivermectin treatment inhibits the replication of porcine circovirus 2 (PCV2) in vitro and mitigates the impact of viral infection in piglets", "author": "Wang", "doi-asserted-by": "crossref", "first-page": "80", "journal-title": "Virus Res.", "key": "10.1016/j.jconrel.2020.10.009_bb0015", "volume": "263", "year": "2019" }, { "DOI": "10.1371/journal.pntd.0006934", "article-title": "Antivirus effectiveness of ivermectin on dengue virus type 2 in Aedes albopictus", "author": "Xu", "doi-asserted-by": "crossref", "journal-title": "PLoS Negl. Trop. Dis.", "key": "10.1016/j.jconrel.2020.10.009_bb0020", "volume": "12", "year": "2018" }, { "DOI": "10.1016/j.antiviral.2015.12.012", "article-title": "Discovery of berberine, abamectin and ivermectin as antivirals against chikungunya and other alphaviruses", "author": "Varghese", "doi-asserted-by": "crossref", "first-page": "117", "journal-title": "Antivir. Res.", "key": "10.1016/j.jconrel.2020.10.009_bb0025", "volume": "126", "year": "2016" }, { "DOI": "10.1016/j.antiviral.2020.104760", "article-title": "The broad spectrum antiviral ivermectin targets the host nuclear transport importin alpha/beta1 heterodimer", "author": "Yang", "doi-asserted-by": "crossref", "first-page": "104760", "journal-title": "Antivir. Res.", "key": "10.1016/j.jconrel.2020.10.009_bb0030", "volume": "177", "year": "2020" }, { "DOI": "10.1016/j.chom.2016.07.004", "article-title": "A screen of FDA-approved drugs for inhibitors of Zika virus infection", "author": "Barrows", "doi-asserted-by": "crossref", "first-page": "259", "journal-title": "Cell Host Microbe", "key": "10.1016/j.jconrel.2020.10.009_bb0035", "volume": "20", "year": "2016" }, { "DOI": "10.1016/j.diagmicrobio.2019.03.012", "article-title": "Lack of efficacy of ivermectin for prevention of a lethal Zika virus infection in a murine system", "author": "Ketkar", "doi-asserted-by": "crossref", "first-page": "38", "journal-title": "Diagn. Microbiol. Infect. Dis.", "key": "10.1016/j.jconrel.2020.10.009_bb0040", "volume": "95", "year": "2019" }, { "DOI": "10.1016/j.antiviral.2020.104787", "article-title": "The FDA-approved drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro", "author": "Caly", "doi-asserted-by": "crossref", "first-page": "104787", "journal-title": "Antivir. Res.", "key": "10.1016/j.jconrel.2020.10.009_bb0045", "volume": "178", "year": "2020" }, { "DOI": "10.1128/JVI.75.9.4399-4401.2001", "article-title": "Measles viruses on throat swabs from measles patients use signaling lymphocytic activation molecule (CDw150) but not CD46 as a cellular receptor", "author": "Ono", "doi-asserted-by": "crossref", "first-page": "4399", "journal-title": "J. Virol.", "key": "10.1016/j.jconrel.2020.10.009_bb0050", "volume": "75", "year": "2001" }, { "article-title": "Histopathologic changes and SARS-CoV-2 imunostaining in the lung of a patient with COVID-19", "author": "Zhang", "first-page": "M20", "journal-title": "Ann. Intern. Med.", "key": "10.1016/j.jconrel.2020.10.009_bb0055", "year": "2020" }, { "DOI": "10.1002/cpt.1889", "article-title": "The approved dose of ivermectin alone is not the Ideal dose for the treatment of COVID-19", "author": "Schmith", "doi-asserted-by": "crossref", "first-page": "762", "journal-title": "Clin. Pharmacol. Ther.", "key": "10.1016/j.jconrel.2020.10.009_bb0060", "volume": "108", "year": "2020" }, { "DOI": "10.1007/s00210-020-01902-5", "article-title": "Ivermectin, antiviral properties and COVID-19: a possible new mechanism of action", "author": "Rizzo", "doi-asserted-by": "crossref", "first-page": "1153", "journal-title": "Naunyn Schmiedeberg’s Arch. Pharmacol.", "key": "10.1016/j.jconrel.2020.10.009_bb0065", "volume": "393", "year": "2020" }, { "DOI": "10.1128/AAC.00086-20", "article-title": "Novel ionophores active against La Crosse virus identified through rapid antiviral screening", "author": "Sandler", "doi-asserted-by": "crossref", "journal-title": "Antimicrob. Agents Chemother.", "key": "10.1016/j.jconrel.2020.10.009_bb0070", "volume": "64", "year": "2020" }, { "DOI": "10.1172/JCI137647", "article-title": "SARS-CoV-2: a storm is raging", "author": "Pedersen", "doi-asserted-by": "crossref", "first-page": "2202", "journal-title": "J. Clin. Invest.", "key": "10.1016/j.jconrel.2020.10.009_bb0075", "volume": "130", "year": "2020" }, { "DOI": "10.1038/s41586-020-2012-7", "article-title": "A pneumonia outbreak associated with a new coronavirus of probable bat origin", "author": "Zhou", "doi-asserted-by": "crossref", "first-page": "270", "journal-title": "Nature.", "key": "10.1016/j.jconrel.2020.10.009_bb0080", "volume": "579", "year": "2020" }, { "DOI": "10.1038/s41586-020-2196-x", "article-title": "Virological assessment of hospitalized patients with COVID-2019", "author": "Wölfel", "doi-asserted-by": "crossref", "first-page": "465", "journal-title": "Nature.", "key": "10.1016/j.jconrel.2020.10.009_bb0085", "volume": "581", "year": "2020" }, { "DOI": "10.1056/NEJMc2001737", "article-title": "SARS-CoV-2 viral load in upper respiratory specimens of infected patients", "author": "Zou", "doi-asserted-by": "crossref", "first-page": "1177", "journal-title": "N. Engl. J. Med.", "key": "10.1016/j.jconrel.2020.10.009_bb0090", "volume": "382", "year": "2020" }, { "DOI": "10.1136/bmj.m1443", "article-title": "Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang Province, China, January-march 2020: retrospective cohort study", "author": "Zheng", "doi-asserted-by": "crossref", "first-page": "m1443", "journal-title": "BMJ.", "key": "10.1016/j.jconrel.2020.10.009_bb0095", "volume": "369", "year": "2020" }, { "DOI": "10.1007/s13555-018-0249-y", "article-title": "Topical ivermectin in the treatment of Papulopustular rosacea: a systematic review of evidence and clinical guideline recommendations", "author": "Ebbelaar", "doi-asserted-by": "crossref", "first-page": "379", "journal-title": "Dermatol. Ther. (Heidelb).", "key": "10.1016/j.jconrel.2020.10.009_bb0100", "volume": "8", "year": "2018" }, { "DOI": "10.1007/s00011-011-0307-8", "article-title": "Anti-inflammatory effects of ivermectin in mouse model of allergic asthma", "author": "Yan", "doi-asserted-by": "crossref", "first-page": "589", "journal-title": "Inflamm. Res.", "key": "10.1016/j.jconrel.2020.10.009_bb0105", "volume": "60", "year": "2011" }, { "DOI": "10.1007/s00011-008-8007-8", "article-title": "Ivermectin inhibits LPS-induced production of inflammatory cytokines and improves LPS-induced survival in mice", "author": "Zhang", "doi-asserted-by": "crossref", "first-page": "524", "journal-title": "Inflamm. Res.", "key": "10.1016/j.jconrel.2020.10.009_bb0110", "volume": "57", "year": "2008" }, { "DOI": "10.1186/s13063-020-04421-z", "author": "Chaccour", "doi-asserted-by": "crossref", "first-page": "498", "journal-title": "Trials.", "key": "10.1016/j.jconrel.2020.10.009_bb0115", "volume": "21", "year": "2020" }, { "DOI": "10.1016/j.ejpb.2019.09.002", "article-title": "Challenges and strategies in drug delivery systems for treatment of pulmonary infections", "author": "Ho", "doi-asserted-by": "crossref", "first-page": "110", "journal-title": "Eur. J. Pharm. Biopharm.", "key": "10.1016/j.jconrel.2020.10.009_bb0120", "volume": "144", "year": "2019" }, { "DOI": "10.1016/j.addr.2014.10.022", "article-title": "Inhaled formulations and pulmonary drug delivery systems for respiratory infections", "author": "Zhou", "doi-asserted-by": "crossref", "first-page": "83", "journal-title": "Adv. Drug Deliv. Rev.", "key": "10.1016/j.jconrel.2020.10.009_bb0125", "volume": "85", "year": "2015" }, { "DOI": "10.3390/pharmaceutics11030113", "article-title": "Strategies to enhance drug absorption via nasal and pulmonary routes", "author": "Ghadiri", "doi-asserted-by": "crossref", "first-page": "113", "journal-title": "Pharmaceutics.", "key": "10.1016/j.jconrel.2020.10.009_bb0130", "volume": "11", "year": "2019" }, { "DOI": "10.1007/s11095-006-0162-4", "article-title": "Oral absorption of poorly water-soluble drugs: computer simulation of fraction absorbed in humans from a miniscale dissolution test", "author": "Takano", "doi-asserted-by": "crossref", "first-page": "1144", "journal-title": "Pharm. Res.", "key": "10.1016/j.jconrel.2020.10.009_bb0140", "volume": "23", "year": "2006" }, { "DOI": "10.1021/acsnano.9b02807", "article-title": "Orally administrable therapeutic synthetic nanoparticle for Zika virus", "author": "Surnar", "doi-asserted-by": "crossref", "first-page": "11034", "journal-title": "ACS Nano", "key": "10.1016/j.jconrel.2020.10.009_bb0145", "volume": "13", "year": "2019" }, { "DOI": "10.2147/IJN.S38378", "article-title": "Nanodrugs: pharmacokinetics and safety", "author": "Onoue", "doi-asserted-by": "crossref", "first-page": "1025", "journal-title": "Int. J. Nanomedicine", "key": "10.1016/j.jconrel.2020.10.009_bb0150", "volume": "9", "year": "2014" }, { "DOI": "10.1007/s00436-017-5510-2", "article-title": "Ivermectin lipid-based nanocarriers as novel formulations against head lice", "author": "Ullio-Gamboa", "doi-asserted-by": "crossref", "first-page": "2111", "journal-title": "Parasitol. Res.", "key": "10.1016/j.jconrel.2020.10.009_bb0155", "volume": "116", "year": "2017" }, { "DOI": "10.1007/s00436-013-3466-4", "article-title": "Improved antifilarial activity of ivermectin in chitosan-alginate nanoparticles against human lymphatic filarial parasite, Brugia malayi", "author": "Ali", "doi-asserted-by": "crossref", "first-page": "2933", "journal-title": "Parasitol. Res.", "key": "10.1016/j.jconrel.2020.10.009_bb0160", "volume": "112", "year": "2013" }, { "DOI": "10.1007/s00436-013-3696-5", "article-title": "Therapeutic efficacy of poly (lactic-co-glycolic acid) nanoparticles encapsulated ivermectin (nano-ivermectin) against brugian filariasis in experimental rodent model", "author": "Ali", "doi-asserted-by": "crossref", "first-page": "681", "journal-title": "Parasitol. Res.", "key": "10.1016/j.jconrel.2020.10.009_bb0165", "volume": "113", "year": "2014" }, { "DOI": "10.3109/02652048.2010.501397", "article-title": "Ivermectin-loaded microparticles for parenteral sustained release: in vitro characterization and effect of some formulation variables", "author": "Camargo", "doi-asserted-by": "crossref", "first-page": "609", "journal-title": "J. Microencapsul.", "key": "10.1016/j.jconrel.2020.10.009_bb0170", "volume": "27", "year": "2010" }, { "article-title": "Liposomal systems as nanocarriers for the antiviral agent Ivermectin", "author": "Croci", "journal-title": "Int. J. Biomater.", "key": "10.1016/j.jconrel.2020.10.009_bb0175", "volume": "8043983", "year": "2016" }, { "DOI": "10.1016/j.drudis.2019.09.023", "article-title": "Physicochemical properties affecting the fate of nanoparticles in pulmonary drug delivery", "author": "Liu", "doi-asserted-by": "crossref", "first-page": "150", "journal-title": "Drug Discov. Today", "key": "10.1016/j.jconrel.2020.10.009_bb0180", "volume": "25", "year": "2020" }, { "DOI": "10.4155/tde-2017-0037", "article-title": "Drug delivery to the lungs: challenges and opportunities", "author": "Newman", "doi-asserted-by": "crossref", "first-page": "647", "journal-title": "Ther. Deliv.", "key": "10.1016/j.jconrel.2020.10.009_bb0185", "volume": "8", "year": "2017" }, { "DOI": "10.3390/ijms15045852", "article-title": "Nanoparticle-mediated pulmonary drug delivery: a review", "author": "Paranjpe", "doi-asserted-by": "crossref", "first-page": "5852", "journal-title": "Int. J. Mol. Sci.", "key": "10.1016/j.jconrel.2020.10.009_bb0190", "volume": "15", "year": "2014" }, { "DOI": "10.3390/pharmaceutics12020171", "article-title": "Nanomaterials designed for antiviral drug delivery transport across biological barriers", "author": "Cojocaru", "doi-asserted-by": "crossref", "first-page": "171", "journal-title": "Pharmaceutics.", "key": "10.1016/j.jconrel.2020.10.009_bb0195", "volume": "12", "year": "2020" }, { "DOI": "10.1021/acsnano.0c02540", "article-title": "Nano research for COVID-19", "author": "Chan", "doi-asserted-by": "crossref", "first-page": "3719", "journal-title": "ACS Nano", "key": "10.1016/j.jconrel.2020.10.009_bb0200", "volume": "14", "year": "2020" } ], "reference-count": 39, "references-count": 39, "relation": {}, "resource": { "primary": { "URL": "https://linkinghub.elsevier.com/retrieve/pii/S0168365920305800" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "Ivermectin: an award-winning drug with expected antiviral activity against COVID-19", "type": "journal-article", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "volume": "329" }